Heron Therapeutics
HRTX
#7833
Rank
NZ$0.42 B
Marketcap
$2.80
Share price
3.27%
Change (1 day)
-1.64%
Change (1 year)

EPS for Heron Therapeutics (HRTX)

EPS in 2023 (TTM): -$1.94

According to Heron Therapeutics's latest financial reports the company's current EPS (TTM) is -$2.07. In 2022 the company made an earnings per share (EPS) of -$3.06 an increase over its 2021 EPS that were of -$3.98.

EPS history for Heron Therapeutics from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$1.94-36.75%
2022-$3.06-23.11%
2021-$3.98-10%
2020-$4.43-0%
2019-$4.431.21%
2018-$4.37-32.7%
2017-$6.50-19.34%
2016-$8.0554.76%
2015-$5.201.73%
2014-$5.12-16.23%
2013-$6.1191.67%
2012-$3.19-31.45%
2011-$4.65-27.06%
2010-$6.37-43.75%
2009-$11.33-57.33%
2008-$26.55-82.92%
2007-$155.4320.61%
2006-$128.87175.76%
2005-$46.73-21.43%
2004-$59.48100%
2003-$29.74-38.24%
2002-$48.15161.54%
2001-$18.41-106.46%
2000$284.822051.55%
1999$13.24839.73%
1998$1.41-105.48%
1997-$25.72-88.16%
1996-$217.28

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$2.30-211.11%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
$0.25-111.97%๐Ÿ‡บ๐Ÿ‡ธ USA
-$2.89 39.32%๐Ÿ‡บ๐Ÿ‡ธ USA
$2.78-234.19%๐Ÿ‡บ๐Ÿ‡ธ USA
-$2.92 41.03%๐Ÿ‡บ๐Ÿ‡ธ USA